Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 36,322 | 40,211 | 31,996 | 14,364 | 18,880 |
| Cost of Goods | 22,249 | 12,985 | 14,701 | 8,245 | 10,683 |
| Gross Profit | 14,073 | 27,226 | 17,295 | 6,119 | 8,197 |
| Operating Expenses | 6,108 | 6,511 | 6,843 | 5,266 | 5,395 |
| Operating Income | 8,214 | 21,700 | 11,154 | 1,098 | 3,485 |
| Interest Expense | 83 | 159 | 189 | 78 | 255 |
| Other Income | 7,559 | -22,105 | 8,307 | -11,673 | -12,749 |
| Pre-tax Income | 15,690 | -564 | 19,272 | -10,653 | -9,519 |
| Income Tax | 1,988 | 5,321 | 2,274 | 239 | 1,517 |
| Net Income Continuous | 13,702 | -5,885 | 16,998 | -10,892 | -11,036 |
| Net Income | $13,702 | $-5,885 | $16,998 | $-10,892 | $-11,036 |
| EPS Basic Total Ops | 0.01 | -0.01 | 0.02 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.01 | -0.01 | 0.02 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.01 | -0.01 | 0.02 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.01 | -0.01 | 0.02 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.01 | 0.01 | -0.01 | 0.00 |
| EBITDA(a) | $8,728 | $22,212 | $11,678 | $1,591 | $4,042 |